178 related articles for article (PubMed ID: 7484753)
1. Serial changes of plasma plasminogen activator inhibitor activity in acute myocardial infarction: difference between thrombolytic therapy and direct coronary angioplasty.
Hirashima O; Ogawa H; Oshima S; Sakamoto T; Honda Y; Sakata S; Masuda T; Miyao Y; Yasue H
Am Heart J; 1995 Nov; 130(5):933-9. PubMed ID: 7484753
[TBL] [Abstract][Full Text] [Related]
2. Comparison of thrombolytic therapies with mutant tPA (lanoteplase/SUN9216) and recombinant tPA (alteplase) for acute myocardial infarction.
Ogata N; Ogawa H; Ogata Y; Numata Y; Morigami Y; Suefuji H; Soejima H; Sakamoto T; Yasue H
Jpn Circ J; 1998 Nov; 62(11):801-6. PubMed ID: 9856594
[TBL] [Abstract][Full Text] [Related]
3. Plasma plasminogen activator inhibitor-1, tissue plasminogen activator and serum lipoprotein(a) after reperfusion therapy in acute myocardial infarction: comparison between sequential and direct percutaneous transluminal coronary angioplasty.
Hara M; Ito K; Nawata T; Tsunematsu Y; Shimoyama N; Maeda T; Sato Y; Saikawa T; Sakata T
Cardiology; 1995; 86(5):407-10. PubMed ID: 7585744
[TBL] [Abstract][Full Text] [Related]
4. Plasma soluble P-selectin in acute myocardial infarction: effects of coronary recanalization therapy.
Tomoda H; Aoki N
Angiology; 1998 Oct; 49(10):807-13. PubMed ID: 9783645
[TBL] [Abstract][Full Text] [Related]
5. Effects of direct percutaneous transluminal coronary angioplasty treatment of acute myocardial infarction on plasma levels of haemostatic and fibrinolytic factors.
Saito M; Nakabayashi T; Iuchi K; Ishikawa T; Kaseno K; Yoshida T; Asakura H; Matsuda T
Blood Coagul Fibrinolysis; 1993 Oct; 4(5):801-4. PubMed ID: 7507363
[TBL] [Abstract][Full Text] [Related]
6. Association of patency of the infarct-related coronary artery with plasma levels of plasminogen activator inhibitor activity in acute myocardial infarction.
Sakamoto T; Yasue H; Ogawa H; Misumi I; Masuda T
Am J Cardiol; 1992 Aug; 70(3):271-6. PubMed ID: 1632387
[TBL] [Abstract][Full Text] [Related]
7. Primary percutaneous transluminal coronary angioplasty accelerates early myocardial reperfusion compared to thrombolytic therapy in patients with acute myocardial infarction.
Zeymer U; Schröder R; Machnig T; Neuhaus KL
Am Heart J; 2003 Oct; 146(4):686-91. PubMed ID: 14564324
[TBL] [Abstract][Full Text] [Related]
8. A new thrombolytic agent, monteplase, is independent of the plasminogen activator inhibitor in patients with acute myocardial infarction: initial results of the COmbining Monteplase with Angioplasty (COMA) trial.
Inoue T; Yaguchi I; Takayanagi K; Hayashi T; Morooka S; Eguchi Y
Am Heart J; 2002 Oct; 144(4):E5. PubMed ID: 12360174
[TBL] [Abstract][Full Text] [Related]
9. Comparative efficacy of primary angioplasty with stent implantation and thrombolysis in restoring basal coronary artery flow in acute ST segment elevation myocardial infarction: quantitative assessment using the corrected TIMI frame count.
Vrachatis AD; Alpert MA; Georgulas VP; Nikas DJ; Petropoulou EN; Lazaros GI; Michelakakis NA; Karavidis AI; Lakoumentas JA; Stergiou L; Zacharoulis AA
Angiology; 2001 Mar; 52(3):161-6. PubMed ID: 11269778
[TBL] [Abstract][Full Text] [Related]
10. High plasminogen activator inhibitor and tissue plasminogen activator levels in plasma precede a first acute myocardial infarction in both men and women: evidence for the fibrinolytic system as an independent primary risk factor.
Thögersen AM; Jansson JH; Boman K; Nilsson TK; Weinehall L; Huhtasaari F; Hallmans G
Circulation; 1998 Nov; 98(21):2241-7. PubMed ID: 9826309
[TBL] [Abstract][Full Text] [Related]
11. Impaired fibrinolysis early after percutaneous transluminal coronary angioplasty is associated with restenosis.
Sakata K; Miura F; Sugino H; Shinobe M; Shirotani M; Yoshida H; Mori N; Hoshino T; Takada A
Am Heart J; 1996 Jan; 131(1):1-6. PubMed ID: 8553994
[TBL] [Abstract][Full Text] [Related]
12. Plasma and platelet plasminogen activator inhibitor-1 in patients with acute myocardial infarction.
Soeki T; Tamura Y; Fukuda N; Ito S
Jpn Circ J; 2000 Aug; 64(8):547-53. PubMed ID: 10952148
[TBL] [Abstract][Full Text] [Related]
13. Correlation of baseline plasminogen activator inhibitor activity with patency of the infarct artery after thrombolytic therapy in acute myocardial infarction.
Barbash GI; Hod H; Roth A; Miller HI; Rath S; Zahav YH; Modan M; Zivelin A; Laniado S; Seligsohn U
Am J Cardiol; 1989 Dec; 64(19):1231-5. PubMed ID: 2511742
[TBL] [Abstract][Full Text] [Related]
14. Correlation between baseline plasminogen activator inhibitor levels and clinical outcome during therapy with tissue plasminogen activator for acute myocardial infarction.
Sane DC; Stump DC; Topol EJ; Sigmon KN; Kereiakes DJ; George BS; Mantell SJ; Macy E; Collen D; Califf RM
Thromb Haemost; 1991 Mar; 65(3):275-9. PubMed ID: 1904653
[TBL] [Abstract][Full Text] [Related]
15. A comparison of immediate angioplasty with thrombolytic therapy for acute myocardial infarction. The Primary Angioplasty in Myocardial Infarction Study Group.
Grines CL; Browne KF; Marco J; Rothbaum D; Stone GW; O'Keefe J; Overlie P; Donohue B; Chelliah N; Timmis GC
N Engl J Med; 1993 Mar; 328(10):673-9. PubMed ID: 8433725
[TBL] [Abstract][Full Text] [Related]
16. Benefit of thrombolytic therapy is sustained throughout five years and is related to TIMI perfusion grade 3 but not grade 2 flow at discharge. The European Cooperative Study Group.
Lenderink T; Simoons ML; Van Es GA; Van de Werf F; Verstraete M; Arnold AE
Circulation; 1995 Sep; 92(5):1110-6. PubMed ID: 7648654
[TBL] [Abstract][Full Text] [Related]
17. Clinical experience with primary percutaneous transluminal coronary angioplasty compared with alteplase (recombinant tissue-type plasminogen activator) in patients with acute myocardial infarction: a report from the Second National Registry of Myocardial Infarction (NRMI-2).
Tiefenbrunn AJ; Chandra NC; French WJ; Gore JM; Rogers WJ
J Am Coll Cardiol; 1998 May; 31(6):1240-5. PubMed ID: 9581714
[TBL] [Abstract][Full Text] [Related]
18. Coronary stenting during rescue angioplasty after failed thrombolysis.
Moreno R; García E; Abeytua M; Soriano J; Elizaga J; Botas J; López-Sendón JL; Delcán JL
Catheter Cardiovasc Interv; 1999 May; 47(1):1-5. PubMed ID: 10385150
[TBL] [Abstract][Full Text] [Related]
19. Percutaneous transluminal coronary angioplasty versus thrombolysis in acute myocardial infarction.
Hansen HH; Thuesen L; Rasmussen K; Andersen HR; Vesterlund T; Villadsen AB; Schroeder AP; Husted SE; Nielsen TT
Scand Cardiovasc J; 2000 Aug; 34(4):365-70. PubMed ID: 10983669
[TBL] [Abstract][Full Text] [Related]
20. Low-dose tissue plasminogen activator followed by planned rescue angioplasty reduces time to reperfusion for acute myocardial infarction treated at community hospitals.
Kimura K; Tsukahara K; Usui T; Okuda J; Kitamura Y; Kosuge M; Sano T; Tohyama S; Yamanaka O; Yoshii Y; Umemura S
Jpn Circ J; 2001 Oct; 65(10):901-6. PubMed ID: 11665796
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
